Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 406

1.

Excellent Locoregional Control in Inflammatory Breast Cancer With a Personalized Radiation Therapy Approach.

Stecklein SR, Rosso KJ, Nuanjing J, Tadros AB, Weiss A, DeSnyder SM, Kuerer HM, Teshome M, Buchholz TA, Stauder MC, Ueno NT, Lucci A, Woodward WA.

Pract Radiat Oncol. 2019 Nov;9(6):402-409. doi: 10.1016/j.prro.2019.05.011. Epub 2019 May 24.

PMID:
31132433
2.

Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical Trial.

Haffty BG, McCall LM, Ballman KV, Buchholz TA, Hunt KK, Boughey JC.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):174-182. doi: 10.1016/j.ijrobp.2019.04.038. Epub 2019 May 11.

PMID:
31085287
3.

Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement.

Christopherson K, Lei X, Barcenas C, Buchholz TA, Garg N, Hoffman KE, Kuerer HM, Mittendorf E, Perkins G, Shaitelman SF, Smith GL, Stauder M, Strom EA, Tereffe W, Woodward WA, Smith BD.

Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):574-581. doi: 10.1016/j.ijrobp.2019.02.049. Epub 2019 Mar 6.

PMID:
30851348
4.

James Daniel Cox, MD, FASTRO, FACR.

Wilson JF, Buchholz TA, Komaki R.

Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):784-785. doi: 10.1016/j.ijrobp.2018.09.025. No abstract available. Erratum in: Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):470.

PMID:
30784520
5.

Optimizing Patient Positioning to Reduce Variation in the Measurement of Breast Cancer-Related Lymphedema.

DeSnyder SM, Kheirkhah P, Travis ML, Lilly SE, Bedrosian I, Buchholz TA, Schaverien MV, Shaitelman SF.

Lymphat Res Biol. 2019 Aug;17(4):440-446. doi: 10.1089/lrb.2018.0018. Epub 2018 Dec 18.

PMID:
30562149
6.

Accelerated partial breast irradiation: Current status with a focus on clinical practice.

Miranda FA, Teixeira LAB, Heinzen RN, de Andrade FEM, Hijal T, Buchholz TA, Moraes FY, Poortmans P, Marta GN.

Breast J. 2019 Jan;25(1):124-128. doi: 10.1111/tbj.13164. Epub 2018 Dec 7. Review.

PMID:
30525258
7.

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update.

Burstein HJ, Lacchetti C, Anderson H, Buchholz TA, Davidson NE, Gelmon KA, Giordano SH, Hudis CA, Solky AJ, Stearns V, Winer EP, Griggs JJ.

J Clin Oncol. 2019 Feb 10;37(5):423-438. doi: 10.1200/JCO.18.01160. Epub 2018 Nov 19.

PMID:
30452337
8.

Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial.

Shaitelman SF, Lei X, Thompson A, Schlembach P, Bloom ES, Arzu IY, Buchholz D, Chronowski G, Dvorak T, Grade E, Hoffman K, Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Amaya DN, Shen Y, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BD.

J Clin Oncol. 2018 Oct 31:JCO1800317. doi: 10.1200/JCO.18.00317. [Epub ahead of print]

PMID:
30379626
9.

A component of lobular carcinoma in clinically lymph node-negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer.

Van Wyhe RD, Caudle AS, Shaitelman SF, Perkins GH, Buchholz TA, Hoffman KE, Strom EA, Smith BD, Tereffe W, Woodward WA, Stauder MC.

Adv Radiat Oncol. 2018 Feb 26;3(3):252-257. doi: 10.1016/j.adro.2018.02.007. eCollection 2018 Jul-Sep.

10.

Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Grossberg AJ, Lei X, Xu T, Shaitelman SF, Hoffman KE, Bloom ES, Stauder MC, Tereffe W, Schlembach PJ, Woodward WA, Buchholz TA, Smith BD.

JAMA Oncol. 2018 Dec 1;4(12):1751-1757. doi: 10.1001/jamaoncol.2018.2583.

11.

Reply to: Mastectomy skin flap thickness.

Marta GN, Poortmans P, de Barros AC, Filassi JR, Freitas-Junior R, Audisio RA, Mano MS, Meterissian S, DeSnyder SM, Buchholz TA, Hijal T.

Eur J Surg Oncol. 2018 Jul;44(7):1119-1120. doi: 10.1016/j.ejso.2018.04.009. Epub 2018 Apr 27. No abstract available.

PMID:
29739639
12.

The role of postmastectomy radiotherapy in patients with stage II breast cancer.

Ohri N, Haffty BG, Buchholz TA.

Cancer. 2018 Feb 1;124(3):450-452. doi: 10.1002/cncr.31130. Epub 2017 Dec 12. No abstract available.

13.

Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis.

Moreno AC, Lin YH, Bedrosian I, Shen Y, Stauder MC, Smith BD, Buchholz TA, Babiera GV, Woodward WA, Shaitelman SF.

Adv Radiat Oncol. 2017 May 3;2(3):291-300. doi: 10.1016/j.adro.2017.04.008. eCollection 2017 Jul-Sep.

14.

Using Discrete-Event Simulation to Promote Quality Improvement and Efficiency in a Radiation Oncology Treatment Center.

Famiglietti RM, Norboge EC, Boving V, Langabeer JR 2nd, Buchholz TA, Mikhail O.

Qual Manag Health Care. 2017 Oct/Dec;26(4):184-189. doi: 10.1097/QMH.0000000000000145.

PMID:
28991813
15.

Multidisciplinary international survey of post-operative radiation therapy practices after nipple-sparing or skin-sparing mastectomy.

Marta GN, Poortmans P, de Barros AC, Filassi JR, Freitas Junior R, Audisio RA, Mano MS, Meterissian S, DeSnyder SM, Buchholz TA, Hijal T.

Eur J Surg Oncol. 2017 Nov;43(11):2036-2043. doi: 10.1016/j.ejso.2017.09.014. Epub 2017 Sep 19.

PMID:
28967564
16.

A phase 2 study of capecitabine and concomitant radiation in women with advanced breast cancer.

Woodward WA, Fang P, Arriaga L, Gao H, Cohen EN, Reuben JM, Valero V, Le-Petross H, Middleton LP, Babiera GV, Strom EA, Tereffe W, Hoffman K, Smith BD, Buchholz TA, Perkins GH.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):777-783. doi: 10.1016/j.ijrobp.2017.04.030. Epub 2017 May 3. Erratum in: Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):497.

17.

A clinical perspective on regional nodal irradiation for breast cancer.

Moreno AC, Shaitelman SF, Buchholz TA.

Breast. 2017 Aug;34 Suppl 1:S85-S90. doi: 10.1016/j.breast.2017.06.035. Epub 2017 Jul 8. Review.

PMID:
28690104
18.

Quantitative Assessment of Breast Cosmetic Outcome After Whole-Breast Irradiation.

Reddy JP, Lei X, Huang SC, Nicklaus KM, Fingeret MC, Shaitelman SF, Hunt KK, Buchholz TA, Merchant F, Markey MK, Smith BD.

Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):894-902. doi: 10.1016/j.ijrobp.2016.12.021. Epub 2016 Dec 21.

19.

Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype.

Symmans WF, Wei C, Gould R, Yu X, Zhang Y, Liu M, Walls A, Bousamra A, Ramineni M, Sinn B, Hunt K, Buchholz TA, Valero V, Buzdar AU, Yang W, Brewster AM, Moulder S, Pusztai L, Hatzis C, Hortobagyi GN.

J Clin Oncol. 2017 Apr 1;35(10):1049-1060. doi: 10.1200/JCO.2015.63.1010. Epub 2017 Jan 30.

20.

MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells.

Bridges KA, Chen X, Liu H, Rock C, Buchholz TA, Shumway SD, Skinner HD, Meyn RE.

Oncotarget. 2016 Nov 1;7(44):71660-71672. doi: 10.18632/oncotarget.12311.

Support Center